Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-08-09

FDA Approved: COSOPT — Supplemental Application (Thea Pharma Inc.)

View source ↗

Summary

FDA approves a supplemental application for COSOPT (dorzolamide hydrochloride and timolol maleate) filed by Thea Pharma Inc. to update or extend its labeling/ap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cosopt (dorzolamide/timolol)

Snippet

SUPPL AP for COSOPT (DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE)